Literature DB >> 10873150

Heterogeneity of clara cell glutathione. A possible basis for differences in cellular responses to pulmonary cytotoxicants.

J A West1, C H Chichester, A R Buckpitt, N K Tyler, P Brennan, C Helton, C G Plopper.   

Abstract

Clara-cell populations show a high degree of variation in susceptibility to injury by bioactivated cytotoxicants. Because glutathione (GSH) is critical for detoxification of electrophilic metabolites, heterogeneity in Clara cell GSH levels may lead to a wide range of cytotoxic responses. This study was designed to define the distinct GSH pools within Clara cells, characterize heterogeneity within the population, and examine whether heterogeneity contributes to susceptibility. Using fluorescent imaging combined with high-performance liquid chromatography analysis, semiquantitative measurements were obtained by evaluation of GSH using monochlorobimane and monobromobimane. In steady-state conditions, the GSH measured in isolated cells was in the femtomole range, but varied 4-fold between individual cells. Clara cells analyzed in situ and in vitro confirmed this heterogeneity. The response of these cells to compounds that modulate GSH was also variable. Diethylmaleate depleted GSH, whereas GSH monoethylester augmented it. However, both acted nonuniformly in isolated Clara cells. The depletion of intracellular GSH caused a striking decrease in cell viability upon incubation with naphthalene (NA). The sulfhydryl-binding fluorochrome BODIPY, which colocalized with tetramethylrosamine, a mitochondrial dye, demonstrated by confocal microscopy that cellular sulfhydryls are highest in the mitochondria, next-highest in cytoplasm, and lowest in the nucleus. These pools responded differently to modulators of GSH. We concluded that the steady-state intracellular GSH of Clara cells exists in distinct pools and is highly heterogeneous within the population, and that the heterogeneity of GSH levels corresponds closely to the response of Clara cells to injury by NA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873150     DOI: 10.1165/ajrcmb.23.1.3907

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  5 in total

1.  Discovery of safe and orally effective 4-aminoquinaldine analogues as apoptotic inducers with activity against experimental visceral leishmaniasis.

Authors:  Partha Palit; Abhijit Hazra; Arindam Maity; R S K Vijayan; Prabu Manoharan; Sukdeb Banerjee; Nirup B Mondal; Nanda Ghoshal; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

2.  Induction of tolerance to naphthalene in Clara cells is dependent on a stable phenotypic adaptation favoring maintenance of the glutathione pool.

Authors:  Jay A A West; Kurt J Williams; Elina Toskala; Susan J Nishio; Chad A Fleschner; Henry Jay Forman; Alan R Buckpitt; Charles G Plopper
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

3.  In vitro airway models from mice, rhesus macaques, and humans maintain species differences in xenobiotic metabolism and cellular responses to naphthalene.

Authors:  Jacklyn Kelty; Nataliia Kovalchuk; Eric Uwimana; Lei Yin; Xinxin Ding; Laura Van Winkle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2022-07-19       Impact factor: 6.011

4.  Glutathione content as a potential mediator of the vulnerability of cultured fetal cortical neurons to ethanol-induced apoptosis.

Authors:  Shivani Kaushal Maffi; Mary Latha Rathinam; Priscilla P Cherian; William Pate; Rhoda Hamby-Mason; Steven Schenker; George I Henderson
Journal:  J Neurosci Res       Date:  2008-04       Impact factor: 4.164

5.  A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids.

Authors:  Martin L Read; Surjeet Singh; Zubair Ahmed; Mark Stevenson; Simon S Briggs; David Oupicky; Lee B Barrett; Rachel Spice; Mark Kendall; Martin Berry; Jon A Preece; Ann Logan; Leonard W Seymour
Journal:  Nucleic Acids Res       Date:  2005-05-24       Impact factor: 16.971

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.